Russell Investments Group
LYEL icon

Russell Investments Group’s Lyell Immunopharma LYEL Stock Holding History

Russell Investments Group’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-574
Closed -$16.6K – 3748
2024
Q2 		$16.6K Buy
574
+403
+236% +$19.2K ﹤0.01% 2972
2024
Q1 		$7.62K Buy
+171
New +$7.32K ﹤0.01% 2884
2023
Q3 		– Sell
-1,065
Closed -$67.7K – 3583
2023
Q2 		$67.7K Sell
1,065
-2,472
-70% -$137K ﹤0.01% 2676
2023
Q1 		$167K Buy
+3,537
New +$189K ﹤0.01% 2506

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group's LYEL Position: Q3 2024 in Review

Russell Investments Group sold out of Lyell Immunopharma (LYEL) in Q3 2024, closing a stake of 574 shares — an estimated $16.6K sold.

Russell Investments Group first reported a position in LYEL in Q1 2023 and held it in 4 quarters. The position peaked at $167K in Q1 2023. 117 funds tracked by Wall St. Rank hold LYEL as of Q3 2024.

  • Russell Investments Group reported no remaining Lyell Immunopharma position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 574 Lyell Immunopharma shares in Q3 2024, an estimated $16.6K.
  • Russell Investments Group first reported a position in Lyell Immunopharma in Q1 2023 and held it in 4 quarters.
  • Russell Investments Group's Lyell Immunopharma position peaked at $167K in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.